Desvenlafaxine Succinate Tablet, Extended Release
Pricing Report NDC 33342-389-07

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

The current wholesale acquisition cost for Desvenlafaxine Succinate (NDC 33342-389-07) is $0.42047 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 17, 2026.

As a a human prescription drug provided by Macleods Pharmaceuticals Limited, this medication is distributed in a 30 TABLET, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.42047
Per EA

Effective Date
Jun 17, 2026
Billable Units
30 EA
Estimated Package Price
$12.61
Data Status
As of Jul 08, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 TABLET, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Dec 2025, the NADAC wholesale price for (NDC ) has moved within a range of $0.42047 to $0.44549 per EA. Over this 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.4205 - $0.4455
Market Volatility
5.95% Variance
Latest Trend
1.39%
Date Unit Price Unit Source Method Rate
Jun 17, 2026 $0.42047 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jun 17, 2026 $0.42047 EAC/I - Chain or Independent PharmacyCode 1G - Generic
May 20, 2026 $0.42640 EAC/I - Chain or Independent PharmacyCode 1G - Generic
May 20, 2026 $0.42640 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Apr 22, 2026 $0.42872 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Apr 22, 2026 $0.42872 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 18, 2026 $0.43287 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 18, 2026 $0.43287 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 18, 2026 $0.43204 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 18, 2026 $0.43204 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jan 21, 2026 $0.44513 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jan 21, 2026 $0.44513 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 17, 2025 $0.44549 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 17, 2025 $0.44549 EAC/I - Chain or Independent PharmacyCode 1G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026